Role of Terminal Heterocyclic Ring on Mesomorphic Properties of Homologous Series*
作者:B. T. Thaker、B. S. Patel、D. B. Solanki、Y. T. Dhimmer、J. S. Dave
DOI:10.1080/15421400903290501
日期:2010.2.25
new homologous series of compounds with a heterocyclicring having sulfur and oxygen as a hetero atom derived from p-hydroxy acetophenone and alkoxy aniline containing cinnamate-azomethine as central linkages have been synthesized. viz. 4(furalacryloxy) α-methyl benzylidine-4′-alkoxy aniline and 4(thianylacryloxy) α-methyl benzylidine-4′-alkoxy aniline. The compound of both the series have been characterized
Novel calamitic side-chain metallomesogenic polymers with ferrocene in the backbone: synthesis and properties of thermotropic liquid-crystalline poly(ferrocenylsilanes)
作者:Xiao-Hua Liu、Duncan W. Bruce、Ian Manners
DOI:10.1039/a607238k
日期:——
Novel thermotropic, metallomesogenic polymers with a
poly(ferrocenylsilane) main chain and
4-pentoxy-4′-hydroxyhexanoxyazobenzene or
4-pentoxy-4′-hydroxy-undecyloxyazobenzene acrylate side chains have
been prepared; each material displays a nematic mesophase.
Study of the molecular structure on liquid crystal properties with reference to thermotropic azoester derivatives
作者:Vinay S. Sharma、U. H. Jadeja、R. B. Patel
DOI:10.1080/15421406.2016.1262681
日期:2017.1.22
ABSTRACT An azoester homologues series: RO‒C6H4‒COO‒C10H6‒N˭N‒C6H4‒OC5H11 (para) as novel liquid crystalline (LC) materials has been synthesized and studied with a view to understanding and establishing the effects of molecularstructure on LC properties with reference to laterally substituted phenyl ring and terminally substituted ‒OR and ‒OC5H11 (n) groups; including ‒COO‒ and ‒N˭N‒ central bridges
[EN] THIAZOLE OR IMIDAZOLE DERIVATIVES AS MAILLARD REACTION INHIBITORS<br/>[FR] DERIVES DE THIAZOLE OU D'IMIDAZOLE INHIBANT LA REACTION DE MAILLARD
申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:WO1994019335A1
公开(公告)日:1994-09-01
(EN) A compound represented by formula (I) is disclosed, wherein the all symbols are defined in the disclosure. A process for producing the compound, and a method for treating diseases caused by a Maillard reaction in living body using the compound are also disclosed.(FR) On décrit un composé représenté par la formule (I), où tous les symboles correspondent aux définitions de la description. On décrit aussi un procédé permettant de produire ce composé et un procédé permettant de traiter des maladies provoquées par une réaction de Maillard chez un être vivant, grâce à ce composé.